Characterization of interference with 6 commercial Δ9- tetrahydrocannabinol immunoassays by efavirenz (glucuronide) in urine [4]

Clinical Chemistry

Volumn 52, Issue 5, 2006, Pages 896-897

  Rossi, Steven ^a   Yaksh, Tony ^a   Bentley, Heather ^b   Van Den Brande, Geoffrey ^b   Grant, Igor ^b   Ellis, Ronald ^c  

^a University of California   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABIS; DRONABINOL; EFAVIRENZ; TETRAHYDROCANNABINOLIC ACID;

CROSS REACTION; DRUG ABUSE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; LETTER; SAMPLING; SCREENING; URINALYSIS;

ANTI-HIV AGENTS; CROSS REACTIONS; FALSE POSITIVE REACTIONS; GLUCURONIDES; HALLUCINOGENS; HUMANS; IMMUNOASSAY; OXAZINES; SUBSTANCE ABUSE DETECTION; TETRAHYDROCANNABINOL;

CANNABIS; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 33646354920     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2006.067058     Document Type: Letter

References (4)

1. BMS Virology. Sustiva. Document 6495-07. Princeton, NJ: Bristol-Myers-Squibb Company, 2002.
2. Sinicco A, Raiteri R, Rossaati A, Savarino A, Di Perri G. Efavirenz interference in estradiol ELISA assay. Clin Chem 2000;46:734-5.
3. Mutlib AE, Chen H, Nemeth GA, Markwalder JA, Seitz SP, Gan LS, et al. Identification and characterization of efavirenz metabolites by liquid chromatography/mass spectrometry and high field NMR: species differences in the metabolism of efavirenz. Drug Metab Dispos 1999;27:1319-33.
4. 9- tetrahydrocannabinol (THC), 11-hydroxy-THC, and 11-nor-9carboxy-THC in human plasma using solid phase extraction and gas chromatography mass spectrometry with positive chemical ionization. J Chromatogr B Analyt Technol Biomed Life Sci 2003;798:145-54.